Genetic Testing Market Growth, Size, Trends Analysis - By Offering, By Test Type, By Method, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Description

Genetic Testing Market Introduction and Overview

According to SPER market research, 'Global Genetic Testing Market Size- By Offering, By Test Type, By Method, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034' state that the Global Genetic Testing Market is predicted to reach 92.58 billion by 2034 with a CAGR of 22.71%.

Genetic testing involves the evaluation of chromosomes, proteins, and particular metabolites in order to detect heritable disease-related genotypes, mutations, phenotypes, or karyotypes for therapeutic use. Prenatal testing, predictive and presymptomatic testing, diagnostic testing, carrier testing, and preimplantation testing are all examples of applications that frequently use high-throughput sequencing technologies like next-generation sequencing.

Restraints: The genetic testing rate has significantly increased in recent years. However, the high cost of testing limits many people from accessing it for detecting various genetic disorders. The average cost is high in many parts of the world, leaving a substantial portion of the population unable to undergo testing.

The high costs come from expensive equipment and instruments used in testing. Additionally, many genetic tests take a long time to provide results, making them less desirable in emergencies. These issues are likely to hinder the growth of the global genetic testing market.

Scope of the Report:

Report Metric Details

Market size available for years 2021-2034

Base year considered 2024

Forecast period 2025-2034

Segments covered By Offering, By Test Type, By Method, By End User.

Regions covered

North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa.

Companies Covered

Illumina, Inc, Thermo Fisher Scientific Inc, F. Hoffmann-La Roche Ltd, OPKO Health Inc, Natera, Inc, PerkinElmer, Inc, Myriad Genetics, Inc, Centogene N.V, Konica Minolta, Inc, Fulgent Genetics, Inc.

Genetic Testing Market Segmentation:

By Offering: Based on the Offering, Global Genetic Testing Market is segmented as; Consumables, Reagents, Instruments, Services.

By Test Type: Based on the Test Type, Global Genetic Testing Market is segmented as; Diagnostic, Prenatal, Carrier, Newborn, Preimplantation.

By Method: Based on the Method, Global Genetic Testing Market is segmented as; Molecular, Chromosomal.

By End User: Based on the End User, Global Genetic Testing Market is segmented as; Hospitals, Diagnostic Laboratories.

By Region: This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa.

Product Code: HLCA2544

1. Introduction

1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology

2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPERs internal database
- 2.1.4. Premium insight from KOLs
2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges

5. Market variable and outlook

5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
5.3. PORTERs Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
5.4. Heat Map Analysis

6. Competitive Landscape

6.1. Global Genetic Testing Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Genetic Testing Market

7. Global Genetic Testing Market, By Offering (USD Million) 2021-2034

7.1. Consumables
7.2. Reagents
7.3. Instruments
7.4. Services

8. Global Genetic Testing Market, By Test Type (USD Million) 2021-2034

8.1. Diagnostic
8.2. Prenatal
8.3. Carrier
8.4. Newborn
8.5. Preimplantation

9. Global Genetic Testing Market, By Method (USD Million) 2021-2034

9.1. Molecular
9.2. Chromosomal

10. Global Genetic Testing Market, By End User (USD Million) 2021-2034

10.1. Hospitals
10.2. Diagnostic Laboratories

11. Global Genetic Testing Market, (USD Million) 2021-2034

11.1. Global Genetic Testing Market Size and Market Share

12. Global Genetic Testing Market, By Region, (USD Million) 2021-2034

12.1. Asia-Pacific
- 12.1.1. Australia
- 12.1.2. China
- 12.1.3. India
- 12.1.4. Japan
- 12.1.5. South Korea
- 12.1.6. Rest of Asia-Pacific
12.2. Europe
- 12.2.1. France
- 12.2.2. Germany
- 12.2.3. Italy
- 12.2.4. Spain
- 12.2.5. United Kingdom
- 12.2.6. Rest of Europe
12.3. Middle East and Africa
- 12.3.1. Kingdom of Saudi Arabia
- 12.3.2. United Arab Emirates
- 12.3.3. Qatar
- 12.3.4. South Africa
- 12.3.5. Egypt
- 12.3.6. Morocco
- 12.3.7. Nigeria
- 12.3.8. Rest of Middle-East and Africa
12.4. North America
- 12.4.1. Canada
- 12.4.2. Mexico
- 12.4.3. United States
12.5. Latin America
- 12.5.1. Argentina
- 12.5.2. Brazil
- 12.5.3. Rest of Latin America

13. Company Profile

13.1. Illumina, Inc
- 13.1.1. Company details
- 13.1.2. Financial outlook
- 13.1.3. Product summary
- 13.1.4. Recent developments
13.2. Thermo Fisher Scientific Inc
- 13.2.1. Company details
- 13.2.2. Financial outlook
- 13.2.3. Product summary
- 13.2.4. Recent developments
13.3. F. Hoffmann-La Roche Ltd
- 13.3.1. Company details
- 13.3.2. Financial outlook
- 13.3.3. Product summary
- 13.3.4. Recent developments
13.4. OPKO Health Inc
- 13.4.1. Company details
- 13.4.2. Financial outlook
- 13.4.3. Product summary
- 13.4.4. Recent developments
13.5. Natera, Inc
- 13.5.1. Company details
- 13.5.2. Financial outlook
- 13.5.3. Product summary
- 13.5.4. Recent developments
13.6. PerkinElmer, Inc
- 13.6.1. Company details
- 13.6.2. Financial outlook
- 13.6.3. Product summary
- 13.6.4. Recent developments
13.7. Myriad Genetics, Inc
- 13.7.1. Company details
- 13.7.2. Financial outlook
- 13.7.3. Product summary
- 13.7.4. Recent developments
13.8. Centogene N.V
- 13.8.1. Company details
- 13.8.2. Financial outlook
- 13.8.3. Product summary
- 13.8.4. Recent developments
13.9. Konica Minolta, Inc
- 13.9.1. Company details
- 13.9.2. Financial outlook
- 13.9.3. Product summary
- 13.9.4. Recent developments
13.10. Fulgent Genetics, Inc
- 13.10.1. Company details
- 13.10.2. Financial outlook
- 13.10.3. Product summary
- 13.10.4. Recent developments
13.11. Others